医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Seoul Viosys’ Air Purification Disinfector to Reduce Possibility of COVID-19 Infection by One-Thirtieth

2021年10月05日 AM11:41
このエントリーをはてなブックマークに追加


 

ANSAN, South Korea

Seoul Viosys (KOSDAQ: 092190), the leading global compound semiconductor device provider and a subsidiary of Seoul Semiconductor, announced that according to the analysis results of the Korea Centers for Disease Control and Prevention and the Korea Institute of Science and Technology, it was confirmed that the probability of infection could be reduced by 22% when ventilating indoor every 10 minutes while staying together with a confirmed person for more than four hours. Based on a disinfection experiment result conducted by a research team at Seoul Viosys, when using Violeds air purification disinfector that reduces viruses by 90% in 10 minutes it is expected that possibility of indoor COVID-19 infection can be reduced by one-thirtieth to lower it approximately one-sixth from the 22%. Seoul Viosys has a plan to provide global sales companies with its patent licensing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211004006041/en/

(Left) Duration time of meeting and infection risk with ventilation (Source: The Korea Centers for Disease Control and Prevention and the Korea Institute of Science and Technology) (Right) Seoul Viosys’ Violeds air disinfection experiment results (Graphic: Business Wire)

(Left) Duration time of meeting and infection risk with ventilation (Source: The Korea Centers for Disease Control and Prevention and the Korea Institute of Science and Technology) (Right) Seoul Viosys’ Violeds air disinfection experiment results (Graphic: Business Wire)

According to a media briefing of the results of The Korea Centers for Disease Control and Prevention, and The Korea Institute of Science and Technology, it was confirmed that the probability of infection could reduce when people reduce the time to meet and increase frequent ventilation. It is confirmed if somebody stays with the corona-infected person for 12 hours, the probability of infection is 78%, and if stays 4 hours, it is lowered to 50%, and it is reduced to 22% when ventilating indoor every 10 minutes for 4 hours. However, Seoul Viosys expects the probability of infection to be reduced to 3% using Violeds air purification disinfector.

Seoul Viosys’ Violeds air purification disinfector is a product equipped with a Violeds module in an air purifier product and is a true air cleaning solution that prevents the spread of the virus by removing various viruses, bacteria, and fine dust. A typical air purifier’s HEPA filter can usually filter fine dust and droplets of 0.3 micrometers (㎛) or more, but viruses smaller than 0.1 ㎛ in size due to evaporation of moisture can pass through the filter. The triple filter type of Violeds air purification disinfector collects both droplets and fine dust in the indoor air, and its Violeds module also disinfects COVID-19 delta variant inflowing with the droplets by 99% in 5 minutes on the surface of the filter.

“The purification and first clinical use of penicillin discovered by Alexander Fleming had been taken 11 years and a long time to save millions of lives. However, we hope that our Violeds air purification disinfector technology is adopted by global product companies, and interest of government or local government with great leadership to save millions of lives and help small business owners suffered due to COVID-19 pandemic as well,” said Chung-hoon Lee, CEO of Seoul Semiconductor and founder of Seoul Viosys.

About Seoul Viosys

Seoul Viosys is a full-line solution provider for UV LED, VCSEL (Vertical Cavity Surface Emitting Laser), the next-generation light source for 3D sensor and laser, and a single-pixel RGB “Micro Clean Pixel” for displays. Established in 2002 as a subsidiary of Seoul Semiconductor, it captured the No. 1 market share in the UV LED industry (LEDinside, 2020). Seoul Viosys has an extensive UV LED portfolio with all wavelengths range (200nm to 1600nm) including ultraviolet rays (UV), visible rays and infrared rays. It holds more than 4,000 patents related to UV LED technology. Violeds, its flagship UV LED technology, provides a wide range of industries with optimal solutions for strong sterilization and disinfection (UVC), skin regeneration (UVB), water/air purification and effective cultivation for horticulture. In 2018, Seoul Viosys acquired RayCan, a leading optoelectronic specialist, to add the advanced VCSEL technology which supports smartphone facial recognition and autonomous driving, and has started its mass production. In January 2020, it introduced a disruptive “Micro Clean Pixel” that has the potential to be a game-changer in the display market. To learn more, visit http://www.seoulviosys.com/en/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211004006041/en/

CONTACT

Seoul Semiconductor Co., Ltd.

Jeonghee Kim

+82-70-4391-8311

jeonghee.kim@seoulsemicon.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease